Recombinant influenza virus vaccine (CJ Healthcare)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant influenza virus vaccine (CJ Healthcare)

Drug Alias Name重组流感病毒疫苗 - CJ Healthcare

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesHK inno.N Corporation

China Registration ClassN/A

Develop Information

Active CompaniesHK inno.N Corporation

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A